[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
November 1992

Preoperative Chemoradiation and Pancreaticoduodenectomy for Adenocarcinoma of the Pancreas

Author Affiliations

From the Departments of General Surgery (Drs Evans, Byrd, and Ames, and Ms Fenoglio), Clinical Radiotherapy (Dr Rich), Pathology (Drs Cleary and Connelly), and Diagnostic Radiology (Dr Charnsangavej) and the Section of Gastrointestinal Oncology and Digestive Diseases (Dr Levin), The University of Texas M. D. Anderson Cancer Center, Houston.

Arch Surg. 1992;127(11):1335-1339. doi:10.1001/archsurg.1992.01420110083017
Abstract

• Chemoradiation prior to pancreaticoduodenectomy ensures that all patients who undergo resection complete multimodality therapy, avoids resection in patients with rapidly progressive disease, and allows radiation therapy to be delivered to well-oxygenated cells before surgical devascularization. Twenty-eight patients with cytologic or histologic proof of localized adenocarcinoma of the pancreatic head received preoperative chemoradiation (fluorouracil, 300 mg/m2 per day, and 50.4 Gy) with the intent of proceeding to resection; all 28 completed this preoperative therapy. Hospital admission because of gastrointestinal toxic effects was required in nine patients, yet no patient experienced a delay in operation. Restaging was performed 4 to 5 weeks after completion of chemoradiation, and five patients were found to have metastatic disease; the 23 patients without evidence of progressive disease underwent laparotomy. At laparotomy, three patients were found to have unsuspected metastatic disease, three patients had unresectable locally advanced disease, and 17 patients were able to undergo pancreaticoduodenectomy. One perioperative death resulted from myocardial infarction, and perioperative complications occurred in three patients. Histologic evidence of tumor cell injury was present in all resected specimens. Our results suggest that ' coduodenectomy can be performed with a low incidence of complications after chemoradiation for localized adenocarcinoma of the pancreas.

(Arch Surg. 1992;127:1335-1339)

References
1.
Whipple AO, Parsons WV, Mull in CR.  Treatment of carcinoma of the ampulla of Vater . Ann Surg . 1935;102:763-779.Article
2.
Crist DW, Sitzman JV, Cameron JL.  Improved hospital morbidity, mortality, and survival after the Whipple procedure . Ann Surg . 1987;206:358-365.Article
3.
Pellegrini CA, Heck CF, Raper S, Way LW.  An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy . Arch Surg . 1989; 124:778-781.Article
4.
Trede M, Schwall G, Saeger H.  Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality . Ann Surg . 1990;211:447-458.Article
5.
Moertel CG, Childs DS Jr, Reitmeier RJ, Colby MY, Holbrook MA.  Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer . Lancet . 1969;2:865-867.Article
6.
Moertel CG, Frytak S, Hahn RG, et al.  Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads and 5-fluorouracil), high dose radiation and 5-fluorouracil . Cancer . 1981;48:1705-1710.Article
7.
 Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma . Ann Surg . 1979;189:205-208.
8.
 Gastrointestinal Tumor Study Group. Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma . Cancer . 1985;56:2563-2568.Article
9.
 Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparisons of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone . J Nat!Cancer Inst . 1988; 80:751-755.
10.
Kalser MH, Ellenberg SS.  Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection . Arch Surg . 1985;120: 899-903.Article
11.
 Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer . Cancer . 1987;59:2006-2010.Article
12.
Ishikawa O, Ohhigashi H, Teshima T, et al.  Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreaticoduodenal region . J Surg Oncol . 1989;40:143-151.Article
13.
Pilepich MV, Miller HH.  Preoperative irradiation in carcinoma of the pancreas . Cancer . 1980;46:1945-1949.Article
14.
Kopelson G. Curative surgery for adenocarcinoma of the pancreas ampulla of Vater: the role of adjuvant pre- or postoperative radiation therapy. Int J Radiat Oncol Biol Phys . 1983;9:911-915.Article
15.
Hall EJ. Radiobiology for the Radiologist . Philadelphia, Pa: JB Lippincott; 1988:137-163.
16.
Warshaw AL, Fernandez-Del Castillo C.  Pancreatic carcinoma . N Engl J Med . 1992;326:455-465.Article
17.
Splinter TAW, Obertop H, Kok TC,  Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas . J Cancer Res Clin Oncol . 1989;115:200-202.Article
18.
Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH.  Comprehensive criteria for chemotherapy-induced toxicity . Cancer Invest . 1990;8:141-153.
19.
Evans DB, Skibber JM, Ames FC, Rich TA.  Extended surgical resection for adenocarcinoma of the pancreas . Cancer Bull . 1991;43:279-282.
20.
Evans DB, Rich TA, Byrd DR, Ames FC.  Adenocarcinoma of the pancreas: current management of resectable and locally advanced disease . South Med J . 1991;84:566-570.Article
21.
Martin D, Evans DB, Ellis LM, Fenoglio C, Ota DM. Nutritional management after pancreaticoduodenectomy for pancreatic cancer: early postoperative enteral feeding. In: Program of A.S.P.E.N. Clinical Congress; January 21, 1992; Orlando, Fla. Abstract 87.
22.
Shimosato Y, Oboshi S, Baba K.  Histologic evaluation of effects of radiotherapy and chemotherapy for carcinomas . Jpn J Clin Oncol . 1971;1:19-35.
23.
Seifert P, Baker LH, Reed ML, Vaitkevicius VK.  Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma . Cancer . 1975;36:123-128.Article
24.
Byfield JE.  5-Fluorouracil radiation sensitization: a brief review . Invest New Drugs . 1989;7:111-116.
25.
Byfield JE, Chan PYM, Seagren SL.  Radiosensitization of 5-FU: molecular origins and clinical scheduling implications . Proc Am Assoc Cancer Res . 1977; 18:74. Abstract.
26.
Byfield JE, Calabro-Jones P, Klisah I, Kulhanian F.  Pharmacologic requirements for obtaining sensitization of human tumor cells in-vitro to combined 5-fluorouracil or Ftorafur and x-rays . Int J Radiat Oncol Biol Phys . 1982; 8:1923-1933.Article
27.
Rich TA.  Protracted (continuous 5-fluorouracil) infusion with concomitant radiation therapy: indications and results . In: Rotman MT, Rosenthal CJ, eds. Concomitant Continuous Infusion Chemotherapy and Radiation . New York, NY: Springer-Verlag NY Inc; 1991:181-188.
28.
Byfield JE.  Theoretical basis and clinical applications of 5-fluorouracil as a radiosensitizer: an overview . In: Rotman MT, Rosenthal CJ, eds. Concomitant Continuous Infusion Chemotherapy and Radiation . New York, NY: Springer-Verlag NY Inc; 1991:115-127.
29.
Lokich JJ, Bothe A, Fine N.  Phase I study of protracted venous infusion of 5-fluorouracil . Cancer . 1981;48:2565-2568.Article
30.
Rich TA, Lokich JJ, Chaffey JT.  A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy . J Clin Oncol . 1985;3:402-406.
31.
Rich TA, Ajani JA, Ellerbroek NA, Ota DM, Ames FC, Levin B. Low dose continuous infusion 5-fluorouracil with or without cisplatin during external beam radiotherapy for adenocarcinomas of the gastrointestinal tract. In: Proceedings of the International Conference on the Interaction of Radiation Therapy and Systemic Therapy; March 1990; Monterey, Calif. In press.
32.
Warshaw AL.  Implications of peritoneal cytology for staging of early pancreatic cancer . Am J Surg . 1991;161:26-30.Article
33.
Weiss SM, Skibber JM, Mohiuddin M, Rosato FE.  Rapid intra-abdominal spread of pancreatic cancer . Arch Surg . 1985;120:415-416.Article
34.
Ishikawa O, Ohhigashi H, Imaoka S, et al.  Concomitant benefit of preoperative irradiation in preventing pancreas fistula formation after pancreaticoduodenectomy . Arch Surg . 1991;126:885-889.Article
35.
Andrèn-Sandberg A, Ahrèn B, Transberg KG, Bengmark S.  Surgical treatment of pancreatic cancer: the Swedish experience . Int J Pancreatol . 1991;9: 145-151.
36.
Griffin JF, Smalley SR, Jewell W.  Patterns of failure after curative resection of pancreatic carcinoma . Cancer . 1990;66:56-61.Article
37.
Ishikawa O, Ohhigashi H, Sasaki Y, et al.  Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head . Ann Surg . 1988;208:215-220.Article
38.
Ozaki H, Kinoshita T, Kosuge T, Egawa S, Kishi K.  Effectiveness of multimodality treatment for resectable pancreatic cancer . Int J Pancreatol . 1990; 7:195-200.
39.
Tepper J, Nardi G, Suit H.  Carcinoma of the pancreas: review of MGH experience from 1963 to 1973 . Cancer . 1976;37:1519-1524.Article
40.
Termuhlen PM, Evans DB, Ames FC, Byrd DR, Cleary KR, Rich TA. Intraoperative radiation therapy following pancreatic resection. In: Program of the Pancreas Club 26th Annual Meeting; May 9, 1992; San Francisco, Calif.
41.
Hiraoka T, Uchino R, Kanemitsu K, et al.  Combination of intraoperative radiation with resection of cancer of the pancreas . Int J Pancreatol . 1990;7: 201-207.
42.
Arbuck SG.  Overview of chemotherapy for pancreatic cancer . Int J Pancreatol . 1990;7:209-222.
×